Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group

Richard F. Spaide, Glenn J. Jaffe, David Sarraf, K. Bailey Freund, Srinivas R. Sadda, Giovanni Staurenghi, Nadia K. Waheed, Usha Chakravarthy, Philip J. Rosenfeld, Frank G. Holz, Eric H. Souied, Salomon Y. Cohen, Giuseppe Querques, Kyoko Ohno-Matsui, David Boyer, Alain Gaudric, Barbara Blodi, Caroline R. Baumal, Xiaoxin Li, Gabriel J. CoscasAlexander Brucker, Lawrence Singerman, Phil Luthert, Steffen Schmitz-Valckenberg, Ursula Schmidt-Erfurth, Hans E. Grossniklaus, David J. Wilson, Robyn Guymer, Lawrence A. Yannuzzi, Emily Y. Chew, Karl Csaky, Jordi M. Monés, Daniel Pauleikhoff, Ramin Tadayoni, James Fujimoto

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Purpose: To establish a process to evaluate and standardize a state-of-the-art nomenclature for reporting neovascular age-related macular degeneration (AMD) data. Design: Consensus meeting. Participants: An international panel of retina specialists, imaging and image reading center experts, and ocular pathologists. Methods: During several meetings organized under the auspices of the Macula Society, an international study group discussed and codified a set nomenclature framework for classifying the subtypes of neovascular AMD and associated lesion components. Main Outcome Measures: A consensus classification of neovascular AMD. Results: The study group created a standardized working definition of AMD. The components of neovascular AMD were defined and subclassified. Disease consequences of macular neovascularization were delineated. Conclusions: The framework of a consensus nomenclature system, a definition of AMD, and a delineation of the subtypes of neovascular AMD were developed. Establishing a uniform set of definitions will facilitate comparison of diverse patient groups and different studies. The framework presented is modified and updated readily, processes that are anticipated to occur on a periodic basis. The study group suggests that the consensus standards outlined in this article be used in future reported studies of neovascular AMD and clinical practice.

Original languageEnglish (US)
Pages (from-to)616-636
Number of pages21
JournalOphthalmology
Volume127
Issue number5
DOIs
StatePublished - May 2020

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group'. Together they form a unique fingerprint.

  • Cite this

    Spaide, R. F., Jaffe, G. J., Sarraf, D., Freund, K. B., Sadda, S. R., Staurenghi, G., Waheed, N. K., Chakravarthy, U., Rosenfeld, P. J., Holz, F. G., Souied, E. H., Cohen, S. Y., Querques, G., Ohno-Matsui, K., Boyer, D., Gaudric, A., Blodi, B., Baumal, C. R., Li, X., ... Fujimoto, J. (2020). Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. Ophthalmology, 127(5), 616-636. https://doi.org/10.1016/j.ophtha.2019.11.004